BioCentury
ARTICLE | Clinical News

NovoEight turoctocog alfa regulatory update

February 10, 2014 8:00 AM UTC

Novo Nordisk disclosed in its 2013 earnings that last month Japan's Ministry of Health, Labor and Welfare (MHLW) approved NovoEight turoctocog alfa to treat hemophilia A. Novo Nordisk also said it lau...